ALICIA SWINDELL

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family DALLAS, TX NPI 1508552290

General Payments — all program years on this page

$1,518.63

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 59
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $990.49 across 40 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $990.4940

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $528.1419
2024 $990.4940

Records — PY2024 (40)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100320660 Novo Nordisk Inc $16.68 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100481831 Novo Nordisk Inc $16.23 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100520717 Novo Nordisk Inc $16.35 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100601481 Novo Nordisk Inc $20.61 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100608920 Novo Nordisk Inc $16.67 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104357103 AstraZeneca Pharmaceuticals LP $21.37 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104394799 AstraZeneca Pharmaceuticals LP $17.96 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104426689 AstraZeneca Pharmaceuticals LP $15.04 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104625482 AstraZeneca Pharmaceuticals LP $20.30 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104660091 AstraZeneca Pharmaceuticals LP $18.45 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104747853 AstraZeneca Pharmaceuticals LP $14.19 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105423395 AstraZeneca Pharmaceuticals LP $14.98 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105653480 AstraZeneca Pharmaceuticals LP $18.21 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105723631 AstraZeneca Pharmaceuticals LP $20.30 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105782448 AstraZeneca Pharmaceuticals LP $14.54 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105809235 AstraZeneca Pharmaceuticals LP $25.26 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105814261 AstraZeneca Pharmaceuticals LP $16.21 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105863836 AstraZeneca Pharmaceuticals LP $16.31 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105870283 AstraZeneca Pharmaceuticals LP $138.54 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113934682 Paratek Pharmaceuticals, Inc. $15.87 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113934684 Paratek Pharmaceuticals, Inc. $17.23 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113934686 Paratek Pharmaceuticals, Inc. $15.94 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116165087 Amgen Inc. $116.15 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116495740 GlaxoSmithKline, LLC. $18.12 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116680613 GlaxoSmithKline, LLC. $24.84 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116715595 GlaxoSmithKline, LLC. $24.84 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116735372 GlaxoSmithKline, LLC. $24.31 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117696478 Amgen Inc. $24.79 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117696480 Amgen Inc. $24.43 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117696482 Amgen Inc. $30.52 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117696484 Amgen Inc. $26.14 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117696486 Amgen Inc. $11.31 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135444825 Lilly USA, LLC $14.43 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135485203 Lilly USA, LLC $17.57 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139464536 Astellas Pharma US Inc $19.75 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153346485 Dexcom, Inc. $19.99 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153346487 Dexcom, Inc. $19.49 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153346489 Dexcom, Inc. $29.94 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153580351 Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.21 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153764458 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.42 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.